A138610 Stock Overview
NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
NIBEC Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩17,300.00 |
52 Week High | ₩25,900.00 |
52 Week Low | ₩11,430.00 |
Beta | 0.98 |
1 Month Change | -7.24% |
3 Month Change | -1.42% |
1 Year Change | 8.19% |
3 Year Change | -50.99% |
5 Year Change | 81.15% |
Change since IPO | 35.69% |
Recent News & Updates
Shareholder Returns
A138610 | KR Biotechs | KR Market | |
---|---|---|---|
7D | -0.8% | 0.3% | -0.4% |
1Y | 8.2% | 5.7% | 4.5% |
Return vs Industry: A138610 exceeded the KR Biotechs industry which returned 6.7% over the past year.
Return vs Market: A138610 exceeded the KR Market which returned 7.1% over the past year.
Price Volatility
A138610 volatility | |
---|---|
A138610 Average Weekly Movement | 5.7% |
Biotechs Industry Average Movement | 8.4% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.8% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A138610 has not had significant price volatility in the past 3 months.
Volatility Over Time: A138610's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | n/a | Chongpyoung Chung | nibec.co.kr |
NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-gun, South Korea.
NIBEC Co., Ltd. Fundamentals Summary
A138610 fundamental statistics | |
---|---|
Market cap | ₩176.99b |
Earnings (TTM) | -₩6.28b |
Revenue (TTM) | ₩15.70b |
11.3x
P/S Ratio-28.2x
P/E RatioIs A138610 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A138610 income statement (TTM) | |
---|---|
Revenue | ₩15.70b |
Cost of Revenue | ₩7.46b |
Gross Profit | ₩8.24b |
Other Expenses | ₩14.53b |
Earnings | -₩6.28b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -614.24 |
Gross Margin | 52.48% |
Net Profit Margin | -40.02% |
Debt/Equity Ratio | 74.3% |
How did A138610 perform over the long term?
See historical performance and comparison